Author | Fabienne McClanahan, MD, PhD

Articles

Allogeneic Transplantation for Chronic Lymphocytic Leukemia in the Age of Novel Treatment Strategies

June 15, 2016

ByMark-Alexander Schwarzbich, MD|Fabienne McClanahan, MD, PhD|John Gribben, MD

The aim of this review is to summarize the current knowledge on HSCT in CLL and to discuss critically its role in the age of novel treatment strategies.